Researchers at Karolinska Institutet are taking part in three projects funded as part of the EU’s second major investment in research on the new coronavirus sars-cov-2, COVID-19 and the pandemic. The total research grant for KI amounts to just over SEK 14 million.
All in all, the EU is contributing in this call EUR 128 million (just over SEK 1.3 billion) to 23 projects involving 347 research groups spread across 40 countries, complementing the spring’s “fast-start” financing of a number of research projects on COVID-19 and strategies for dealing with the pandemic. The current projects are yet to finalise their contracts with the EU Commission but are expected to commence at some time this autumn.
These are the three projects that KI is involved in:
Project: Pan-European Response to the ImpactS of COVID-19 and future Pandemics and Epidemics; 32 partners from Italy, Austria, Belgium, Switzerland, the Czech Republic, Germany, Spain, France, Luxemburg, the Netherlands, Poland, Romania, Serbia, Sweden and the UK.
Grant: Approx. EUR 10 million (of which 7% to KI).
Project: COVID eXponential Programme; 10 partners from Spain, Cyprus, Italy, Ireland, Luxemburg, Lithuania and Sweden.
Grant: Approx. EUR 7.2 million (6 % to KI).
Leading the research at KI: Carl Johan Sundberg (Department of Learning, Informatics, Management and Ethics).
Project: Improving the Preparedness of Health Systems to Reduce Mental Health and Psychosocial Concerns resulting from the COVID-19 Pandemic; 14 partners from the Netherlands, Australia, Belgium, Germany, Spain, France, Italy, Sweden and the UK.
Grant: Approx. EUR 6.2 million (4% to KI).
Leading the research at KI: Ellenor Mittendorfer Rutz (Department of Clinical Neuroscience).
About the call
The EU’s framework programme Horizon 2020.
Advancing knowledge for the clinical and public health response to the 2019-nCoV epidemic (H2020-SC1-PHE-CORONAVIRUS-2020-2).
This article was first published on 11 September by Karolinska Institutet.